The Board of Inventurus Knowledge Solutions Limited approved a further strategic investment of up to USD 40 Million in its wholly-owned US subsidiary, Inventurus Knowledge Solutions, Inc. (“IKS Inc”). This transaction, conducted on a cash basis, aims to support the subsidiary’s growth in providing care enablement platforms. The Board meeting concluded on March 13, 2026, confirming the continuity of shareholding percentage despite the capital infusion.
Strategic Capital Infusion into US Subsidiary
Inventurus Knowledge Solutions Limited announced that its Board of Directors has sanctioned a significant further investment of up to USD 40 Million into its wholly-owned subsidiary, Inventurus Knowledge Solutions, Inc. (“IKS Inc”). This approval was granted during a Board meeting held on March 13, 2026, which commenced at 07:10 p.m. IST.
Transaction Details
The investment will be made via Cash Consideration. For the initial tranche of USD 20 Million, the cost of acquisition is set at USD 643.19 per share, resulting in the acquisition of up to 31,096 equity shares. The remaining 50% investment is expected to follow in due course. Despite this capital infusion, the Company’s shareholding percentage in IKS Inc will remain the same.
The indicative timeline for the completion of this further investment is set on or before May 31, 2026.
Subsidiary Profile and Financials (IKS Inc.)
IKS Inc., incorporated in Delaware, USA on September 19, 2006, specializes in assisting U.S.-based healthcare service providers through outsourcing and technology, focusing on delivering better and safer care. The transaction is noted as a further investment, and while IKS Inc. is a related party, the transaction is confirmed to be on an “arm’s length” basis.
Financial Summary of IKS Inc. (Amt in INR Mn)
The subsidiary reported solid financials for the last completed fiscal year (FY 2024-25):
- Revenue from Operations: 6,941.11 INR Mn
- Other Income: 55.81 INR Mn
- Total Income: 6,996.92 INR Mn
For historical comparison:
- Revenue from Operations in FY 2023-24 was 7,027.85 INR Mn.
- Revenue from Operations in FY 2022-23 was 6,054.66 INR Mn.
It is confirmed that none of the Company’s promoter or promoter group entities have any interest in this specific transaction.
Source: BSE
